SAN DIEGO, Oct. 8, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that NuVasive Clinical Services has been awarded a three-year, sole source supplier contract for Intraoperative Neuromonitoring (IONM) Services with Premier. Effective November 1, 2018, the new contract allows Premier members the option to take advantage of special pricing and terms pre-negotiated by Premier for IONM services provided by NuVasive Clinical Services (NCS).
NCS is the largest provider of intraoperative neuromonitoring services, covering the full range of spine, brain, and other surgical procedures. IONM can reduce surgical risk by providing critical information and alerts to surgeons of potential harm or compromise to the spinal cord or neural structures. The NuVasive Clinical Services IONM program offers proprietary neuromonitoring technology and is accredited by The Joint Commission. Its staff includes board-certified neurologists and highly trained neurophysiologists who deliver quality, real-time IONM information to surgeons and anesthesiologists. With NCS' national geographical coverage, as well as high standards of service and clinical practices, the Company is well positioned to strategically partner with Premier member hospitals.
"Our goal at NuVasive Clinical Services is to enable making surgeries smarter, more consistent, more predictable and more reliable to help eradicate preventable healthcare injury through the use of intraoperative neuromonitoring," said Dan Siegel, general manager of Global Services at NuVasive. "We are pleased to be working with Premier, as it will provide even more hospitals and healthcare systems access to these services that are proven to help improve patient outcomes during complex surgeries."
Premier is a leading healthcare improvement company, uniting an alliance of approximately 4,000 U.S. hospitals and 165,000 other providers to transform healthcare. With integrated data and analytics, collaborative, supply chain solutions, and advisory and other services, Premier enables better care and outcomes at a lower cost.
NuVasive, Inc. (NASDAQ: NUVA) is the leader in spine technology innovation, focused on transforming spine surgery and beyond with minimally disruptive, procedurally integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. The Company's portfolio includes access instruments, implantable hardware, biologics, software systems for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings. With over $1 billion in revenues, NuVasive has an approximate 2,400 person workforce in more than 40 countries serving surgeons, hospitals and patients. For more information, please visit www.nuvasive.com.
NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company's surgical products and procedures by spine surgeons, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive's products (including the iGA® platform), the Company's ability to effectually manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.
View original content to download multimedia:http://www.prnewswire.com/news-releases/nuvasive-clinical-services-awarded-sole-source-intraoperative-neuromonitoring-services-contract-with-premier-300725519.html
SOURCE NuVasive, Inc.
Investor & Media Contact: Suzanne Hatcher, NuVasive, Inc., 858-458-2240, firstname.lastname@example.org